Dipl ABO

1 month ago | vol175mex.clatinmedia.app | Selina McGee |Dipl ABO

(Este artículo fue traducido y editado con autorización del grupo Jobson Publishing) Hace apenas unos pocos años, la inteligencia artificial (IA) parecía un concepto muy futurista. Mire a su alrededor y verá rápidamente que el futuro ha llegado. Parece que sucedió de repente, pero lo que puede sorprenderle es que la integración de la IA en el cuidado de los ojos se ha estado produciendo durante la mayor parte de una década.

1 month ago | optometrytimes.com | Sherrol A. Reynolds |Jessica Steen |Ashley Wallace-Tucker |Dipl ABO |Jordana Joy

From February 14-17, ophthalmic and optometric professionals gathered at EnVision Summit 2025. Besides soaking up the Puerto Rican sun, ODs shared their expertise on keratoconus, myopia, glaucoma, and everything in between. The Eye Care Network sat down with OD Envision faculty members to hear their insights during the meeting. Sherrol Reynolds, OD, FAAO, weighed in on what she thinks will be the biggest innovations to come in eye care.

2 months ago | optometrytimes.com | Ashley Wallace-Tucker |Dipl ABO |Emily Kaiser Maharjan |Jordana Joy

Currently, the only FDA-approved modality for myopia management is a contact lens, which is insufficient for the diverse needs of children. There is hope for FDA-approved glasses and atropine to expand treatment options. Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, emphasizes the importance of diversifying myopia management tools, noting that not all children can wear contact lenses.

2 months ago | optometrytimes.com | Ashley Wallace-Tucker |Dipl ABO |Emily Kaiser Maharjan |Jordana Joy

Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, one of the faculty members of EnVision Summit 2025, details the importance of comanagement and the opportunities that the conference gave attendees to improve comanagement tactics. Editor's note: The below transcript has been lightly edited for clarity. Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO:I think it's incredible that ophthalmology and optometry are coming together in this conference.

Nov 18, 2024 | optometrytimes.com | Mohammad Rafieetary |Dipl ABO |Jordana Joy

Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses one of his presentations, "Suprachoroidal Delivery of Investigational ABBV-RGX-314 Gene Therapy for Diabetic Retinopathy: The Phase II ALTITUDE Study," which he gave alongside Roya Attar, OD, MBA, DHA at the AAOpt 2024 conference. Editor's note: The below transcript has been lightly edited for clarity. Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO:Hello everybody. This is Mohammad Rafieetary.